This
section contains a list of significant research and review
articles pertaining to pancreatic cancer. The 'Research article'
category contains publications where molecular alterations
at the miRNA, mRNA or protein level were described. The 'Review
articles' category contains reviews that should be of broad
interest to those working on the molecular biology of pancreatic
cancer. If you would like your paper to be considered for
listing in any of these two categories, please use 'Submit
new articles' tab for us to consider your article for inclusion
here. Please note that data from more than 1,000 published
articles has been curated and included in this database although
all of those articles are not listed in the 'Publications'
section here.
Rosty, C. and Goggins, M. Early detection of pancreatic carcinoma. Hematology/oncology Clinics of North America. 2002. 16, 37-52. [PubMed]
2.
Jaffee, E. M., Hruban, R. H., Canto, M. and Kern, S. E. Focus on pancreas cancer. Cancer Cell. 2002. 2, 25-28. [PubMed]
3.
Yeo, T. P., Hruban, R. H., Leach, S. D., Wilentz, R. E., Sohn, T. A., Kern, S. E., Iacobuzio-Donahue, C. A., Maitra, A., Goggins, M., Canto, M. I., Abrams, R. A., Laheru, D., Jaffee, E. M., Hidalgo, M. and Yeo, C. J. Pancreatic cancer. Current Problems in Cancer. 2002. 26, 176-275. [PubMed]
4.
Kern, S. E., Hruban, R. H., Hidalgo, M. and Yeo, C. J. An introduction to pancreatic adenocarcinoma genetics, pathology and therapy. Cancer Biology & Therapy. 2002. 1, 607-613. [PubMed]
5.
Iacobuzio-Donahue, C. A. and Hruban, R. H. Gene expression in neoplasms of the pancreas: applications to diagnostic pathology. Advances in Anatomic Pathology. 2003. 10, 125-134. [PubMed]
6.
Hansel, D. E., Kern, S. E. and Hruban, R. H. Molecular pathogenesis of pancreatic cancer. Annual Review of Genomics and Human Genetics. 2003. 4, 237-256. [PubMed]
7.
Grutzmann, R., Saeger, H. D., Luttges, J., Schackert, H. K., Kalthoff, H., Kloppel, G. and Pilarsky, C. Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspectives. International Journal of Colorectal Disease. 2004. 19, 401-413. [PubMed]
8.
Hruban, R. H., Takaori, K., Klimstra, D. S., Adsay, N. V., Albores-Saavedra, J., Biankin, A. V., Biankin, S. A., Compton, C., Fukushima, N., Furukawa, T., Goggins, M., Kato, Y., Kloppel, G., Longnecker, D. S., Luttges, J., Maitra, A., Offerhaus, G. J., Shimizu, M. and Yonezawa, S. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. The American Journal of Surgical Pathology. 2004. 28, 977-987. [PubMed]
9.
Hruban, R. H., Wilentz, R. E. and Maitra, A. Identification and analysis of precursors to invasive pancreatic cancer. Methods in Molecular Medicine. 2005. 103, 1-13. [PubMed]
10.
Brandt, R., Grutzmann, R., Bauer, A., Jesnowski, R., Ringel, J., Lohr, M., Pilarsky, C. and Hoheisel, J. D. DNA microarray analysis of pancreatic malignancies. Pancreatology : Official Journal of the International Association of Pancreatology . 2004. 4, 587-597. [PubMed]
11.
Chen, R., Pan, S., Brentnall, T. A. and Aebersold, R. Proteomic profiling of pancreatic cancer for biomarker discovery. Molecular & Cellular Proteomics : MCP. 2005. 4, 523-533. [PubMed]
12.
Maitra, A., Fukushima, N., Takaori, K. and Hruban, R. H. Precursors to invasive pancreatic cancer. Advances in Anatomic Pathology. 2005. 12, 81-91. [PubMed]
13.
Khalid, A., Finkelstein, S. and McGrath, K. Molecular diagnosis of solid and cystic lesions of the pancreas. Clinics in Laboratory Medicine. 2005. 25, 101-116. [PubMed]
14.
Lowenfels, A. B. and Maisonneuve, P. Risk factors for pancreatic cancer. Journal of Cellular Biochemistry. 2005. 95, 649-656. [PubMed]
15.
Vimalachandran, D. and Costello, E. Proteomic technologies and their application to pancreatic cancer. Expert Review of Proteomics. 2004. 1, 493-501. [PubMed]
16.
Goggins M. Molecular markers of early pancreatic cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2005. 23, 4524-4531. [PubMed]
17.
Furukawa, T., Kloppel, G., Volkan, A., Albores-Saavedra, J., Fukushima, N., Horii, A., Hruban, R. H., Kato, Y., Klimstra, D. S., Longnecker, D. S., Luttges, J., Offerhaus, G. J., Shimizu, M., Sunamura, M., Suriawinata, A., Takaori, K. and Yonezawa, S. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Archiv : An International Journal of Pathology. 2005. 447, 794-799. [PubMed]
18.
Roda, O., Chiva, C., Espuna, G., Gabius, H. J., Real, F. X., Navarro, P. and Andreu, D. A proteomic approach to the identification of new tPA receptors in pancreatic cancer cells. Proteomics. 2006. 6 Suppl 1, S36-41. [PubMed]
19.
Maitra, A., Kern, S. E. and Hruban, R. H. Molecular pathogenesis of pancreatic cancer. Best Practice & Research. Clinical Gastroenterology. 2006. 20, 211-226. [PubMed]
20.
Okusaka, T., Yamada, T. and Maekawa, M. Serum tumor markers for pancreatic cancer: the dawn of new era? JOP : Journal of the Pancreas. 2006. 7, 332-336. [PubMed]
21.
Beaty, R. M., Gronborg, M., Pollack, J. R. and Maitra, A. Target discovery and validation in pancreatic cancer. Methods in Molecular Biology. 2007. 360, 57-89. [PubMed]
22.
Feldmann, G., Beaty, R., Hruban, R. H. and Maitra, A. Molecular genetics of pancreatic intraepithelial neoplasia. Journal of Hepato-biliary-pancreatic Surgery. 2007. 14, 224-232. [PubMed]
23.
Hruban, R. H., Takaori, K., Canto, M., Fishman, E. K., Campbell, K., Brune, K., Kern, S. E. and Goggins, M. Clinical importance of precursor lesions in the pancreas. Journal of Hepato-biliary-pancreatic Surgery. 2007. 14, 255-263. [PubMed]
24.
Goggins M. Identifying molecular markers for the early detection of pancreatic neoplasia. Seminars in Oncology. 2007. 34, 303-310. [PubMed]
25.
Brand, R. E., Lerch, M. M., Rubinstein, W. S., Neoptolemos, J. P., Whitcomb, D. C., Hruban, R. H., Brentnall, T. A., Lynch, H. T. and Canto, M. I. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut. 2007. 56, 1460-1469. [PubMed]
26.
Hruban, R. H., Maitra, A., Kern, S. E. and Goggins, M. Precursors to pancreatic cancer. Gastroenterology Clinics of North America. 2007. 36, 831-880. [PubMed]
27.
Maitra, A. and Hruban, R. H. Pancreatic cancer. Annual Review of Pathology. 2008. 3, 157-188. [PubMed]
28.
Feldmann, G. and Maitra, A. Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts. The Journal of Molecular Diagnostics : JMD. 2008. 10, 111-122. [PubMed]
29.
Fry, L. C., Monkemuller, K. and Malfertheiner, P. Molecular markers of pancreatic cancer: development and clinical relevance. Langenbeck's Archives of Surgery / Deutsche Gesellschaft Fur Chirurgie. 2008. 393, 883-890. [PubMed]
30.
Grantzdorffer, I., Carl-McGrath, S., Ebert, M. P. and Rocken, C. Proteomics of pancreatic cancer. Pancreas. 2008. 36, 329-336. [PubMed]
31.
Shi, C., Daniels, J. A. and Hruban, R. H. Molecular characterization of pancreatic neoplasms. Advances in Anatomic Pathology. 2008. 15, 185-195. [PubMed]
32.
Hruban, R. H., Klein, A. P., Eshleman, J. R., Axilbund, J. E. and Goggins, M. Familial pancreatic cancer: from genes to improved patient care. Expert Review of Gastroenterology & Hepatology. 2007. 1, 81-88. [PubMed]
33.
Shi, C., Hruban, R. H. and Klein, A. P. Familial pancreatic cancer. Archives of Pathology & Laboratory Medicine. 2009. 133, 365-374. [PubMed]
34.
Harsha, H. C., Kandasamy, K., Ranganathan, P., Rani, S., Ramabadran, S., Gollapudi, S., Balakrishnan, L., Dwivedi, S. B., Telikicherla, D., Selvan, L. D., Goel, R., Mathivanan, S., Marimuthu, A., Kashyap, M., Vizza, R. F., Mayer, R. J., Decaprio, J. A., Srivastava, S., Hanash, S. M., Hruban, R. H. and Pandey, A. A compendium of potential biomarkers of pancreatic cancer. PLoS Medicine. 2009. 6, e1000046. [PubMed]
35.
Hruban, R. H. and Adsay, N. V. Molecular classification of neoplasms of the pancreas. Human Pathology. 2009. 40, 612-623. [PubMed]
36.
Tonack, S., Aspinall-O'Dea, M., Neoptolemos, J. P. and Costello, E. Pancreatic cancer: proteomic approaches to a challenging disease. Pancreatology : Official Journal of the International Association of Pancreatology . 2009. 9, 567-576. [PubMed]
37.
Lonardo, E., Hermann, P. C. and Heeschen, C. Pancreatic cancer stem cells - update and future perspectives. Molecular Oncology. 2010. 4, 431-442. [PubMed]
38.
Lopez-Casas, P. P. and Lopez-Fernandez, L. A. Gene-expression profiling in pancreatic cancer. Expert Review of Molecular Diagnostics. 2010. 10, 591-601. [PubMed]
39.
Nakajima, Y., Yamada, T. and Sho, M. Malignant potential of intraductal papillary mucinous neoplasms of the pancreas. Surgery Today. 2010. 40, 816-824. [PubMed]
40.
Dumitrescu, D., Popescu, C. F. and Saftoiu, A. Intraductal papillary mucinous tumors of the pancreas. Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie et Embryologie. 2010. 51, 447-453. [PubMed]
41.
Morris, J. P., Wang, S. C. and Hebrok, M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nature Reviews. Cancer. 2010. 10, 683-695. [PubMed]
42.
Miyoshi, E., Shinzaki, S., Moriwaki, K. and Matsumoto, H. Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test. Methods in Enzymology. 2010. 478, 153-164. [PubMed]
43.
Pawa, N., Wright, J. M. and Arulampalam, T. H. Mass spectrometry based proteomic profiling for pancreatic cancer. JOP : Journal of the Pancreas. 2010. 11, 423-426. [PubMed]
44.
Tanase, C. P., Neagu, M., Albulescu, R. and Hinescu, M. E. Advances in pancreatic cancer detection. Advances in Clinical Chemistry. 2010. 51, 145-180. [PubMed]
45.
Haugk B. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer? Histopathology. 2010. 57, 503-514. [PubMed]
46.
Thosani, N., Dasari, C. S., Bhutani, M. S., Raimondo, M. and Guha, S. Molecular pathogenesis of intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2010. 39, 1129-1133. [PubMed]
47.
Chakraborty, S., Baine, M. J., Sasson, A. R. and Batra, S. K. Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochimica et Biophysica Acta. 2011. 1815, 44-64. [PubMed]
48.
Cano, C. E., Motoo, Y. and Iovanna, J. L. Epithelial-to-mesenchymal transition in pancreatic adenocarcinoma. TheScientificWorldJournal. 2010. 10, 1947-1957. [PubMed]
49.
Cutts, R. J., Gadaleta, E., Hahn, S. A., Crnogorac-Jurcevic, T., Lemoine, N. R. and Chelala, C. The Pancreatic Expression database: 2011 update. Nucleic Acids Research. 2011. 39, D1023-8. [PubMed]
50.
Neesse, A., Michl, P., Frese, K. K., Feig, C., Cook, N., Jacobetz, M. A., Lolkema, M. P., Buchholz, M., Olive, K. P., Gress, T. M. and Tuveson, D. A. Stromal biology and therapy in pancreatic cancer. Gut. 2011. 60, 861-868. [PubMed]
51.
Buxbaum, J. L. and Eloubeidi, M. A. Molecular and clinical markers of pancreas cancer. JOP : Journal of the Pancreas. 2010. 11, 536-544. [PubMed]
52.
Rhim, A. D. and Stanger, B. Z. Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways. Progress in Molecular Biology and Translational Science. 2010. 97, 41-78. [PubMed]
53.
Maisonneuve, P. and Lowenfels, A. B. Epidemiology of pancreatic cancer: an update. Digestive Diseases. 2010. 28, 645-656. [PubMed]
54.
Wang, Z., Li, Y., Ahmad, A., Banerjee, S., Azmi, A. S., Kong, D. and Sarkar, F. H. Pancreatic cancer: understanding and overcoming chemoresistance. Nature Reviews. Gastroenterology & Hepatology. 2011. 8, 27-33. [PubMed]
55.
Kern, S. E., Shi, C. and Hruban, R. H. The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting. The Journal of Pathology. 2011. 223, 295-306. [PubMed]
56.
Testini, M., Gurrado, A., Lissidini, G., Venezia, P., Greco, L. and Piccinni, G. Management of mucinous cystic neoplasms of the pancreas. World Journal of Gastroenterology : WJG. 2010. 16, 5682-5692. [PubMed]
57.
Grutzmann, R., Niedergethmann, M., Pilarsky, C., Kloppel, G. and Saeger, H. D. Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. The Oncologist. 2010. 15, 1294-1309. [PubMed]
58.
Bunger, S., Laubert, T., Roblick, U. J. and Habermann, J. K. Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview. Journal of Cancer Research and Clinical Oncology. 2011. 137, 375-389. [PubMed]
59.
Cecconi, D., Palmieri, M. and Donadelli, M. Proteomics in pancreatic cancer research. Proteomics. 2011. 11, 816-828. [PubMed]
60.
Ucar, D. A. and Hochwald, S. N. FAK and interacting proteins as therapeutic targets in pancreatic cancer. Anti-cancer Agents in Medicinal Chemistry. 2010. 10, 742-746. [PubMed]
61.
Duner, S., Lopatko, L., Ansari, D., Gundewar, C. and Andersson, R. Pancreatic cancer: the role of pancreatic stellate cells in tumor progression. Pancreatology : Official Journal of the International Association of Pancreatology . 2010. 10, 673-681. [PubMed]
62.
Greer, J. B. and Brand, R. E. New developments in pancreatic cancer. Current Gastroenterology Reports. 2011. 13, 131-139. [PubMed]
63.
Costello, E. and Neoptolemos, J. P. Pancreatic cancer in 2010: new insights for early intervention and detection. Nature Reviews. Gastroenterology & Hepatology. 2011. 8, 71-73. [PubMed]
64.
Lomberk G. A. Epigenetic silencing of tumor suppressor genes in pancreatic cancer. Journal of Gastrointestinal Cancer. 2011. 42, 93-99. [PubMed]
65.
Yang, F., Jin, C., Jiang, Y., Li, J., Di, Y., Ni, Q. and Fu, D. Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside. Cancer Treatment Reviews. 2011. 37, 633-642. [PubMed]
66.
Al-Haddad, M., Schmidt, M. C., Sandrasegaran, K. and Dewitt, J. Diagnosis and treatment of cystic pancreatic tumors. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 2011. 9, 635-648. [PubMed]
67.
Erkan, M., Reiser-Erkan, C., Michalski, C. W. and Kleeff, J. Tumor microenvironment and progression of pancreatic cancer. Experimental Oncology. 2010. 32, 128-131. [PubMed]
68.
Campen, C. J., Dragovich, T. and Baker, A. F. Management strategies in pancreatic cancer. American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists. 2011. 68, 573-584. [PubMed]
69.
Scarlett, C. J., Salisbury, E. L., Biankin, A. V. and Kench, J. Precursor lesions in pancreatic cancer: morphological and molecular pathology. Pathology. 2011. 43, 183-200. [PubMed]
70.
Jamieson, N. B., Carter, C. R., McKay, C. J. and Oien, K. A. Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 2011. 17, 3316-3331. [PubMed]
71.
Smith, R. A., Tang, J., Tudur-Smith, C., Neoptolemos, J. P. and Ghaneh, P. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. British Journal of Cancer. 2011. 104, 1440-1451. [PubMed]
72.
Castellanos, E. H., Cardin, D. B. and Berlin, J. D. Treatment of early-stage pancreatic cancer. Oncology. 2011. 25, 182-189. [PubMed]
73.
Almhanna, K. and Philip, P. A. Defining new paradigms for the treatment of pancreatic cancer. Current Treatment Options in Oncology. 2011. 12, 111-125. [PubMed]
74.
Dodson, L. F., Hawkins, W. G. and Goedegebuure, P. Potential targets for pancreatic cancer immunotherapeutics. Immunotherapy. 2011. 3, 517-537. [PubMed]
75.
Lin, J. C., Chan, D. C., Chen, P. J., Chu, H. C., Chueh, T. H., Huang, H. H., Chang, P. Y., Yu, C. P., Chang, W. K. and Hsieh, T. Y. Clinical characteristics of early onset pancreatic adenocarcinoma: a medical center experience and review of the literature. Pancreas. 2011. 40, 638-639. [PubMed]
76.
Castellanos, E., Berlin, J. and Cardin, D. B. Current treatment options for pancreatic carcinoma. Current Oncology Reports. 2011. 13, 195-205. [PubMed]
77.
Rialon, K. L. and White, R. R. Aptamers: potential applications to pancreatic cancer therapy. Anti-cancer Agents in Medicinal Chemistry. 2011. 11, 434-441. [PubMed]
78.
Krautz, C., Ruckert, F., Saeger, H. D., Pilarsky, C. and Grutzmann, R. An update on molecular research of pancreatic adenocarcinoma. Anti-cancer Agents in Medicinal Chemistry. 2011. 11, 411-417. [PubMed]
79.
Conroy, T., Gavoille, C. and Adenis, A. Metastatic pancreatic cancer: old drugs, new paradigms. Current Opinion in Oncology. 2011. 23, 390-395. [PubMed]
80.
Ottenhof, N. A., de, W., Maitra, A., Hruban, R. H. and Offerhaus, G. J. Molecular characteristics of pancreatic ductal adenocarcinoma. Pathology Research International. 2011. 2011, 620601. [PubMed]
81.
Assifi, M. M. and Hines, O. J. Anti-angiogenic agents in pancreatic cancer: a review. Anti-cancer Agents in Medicinal Chemistry. 2011. 11, 464-469. [PubMed]
82.
Falasca, M., Selvaggi, F., Buus, R., Sulpizio, S. and Edling, C. E. Targeting phosphoinositide 3-kinase pathways in pancreatic cancer--from molecular signalling to clinical trials. Anti-cancer Agents in Medicinal Chemistry. 2011. 11, 455-463. [PubMed]
83.
Ashida, R., Arisaka, Y., Masuda, D., Takii, M. and Higuchi, K. The role of linear array EUS for diagnosis of pancreatic malignancies in the current situation. Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society. 2011. 23 Suppl 1, 12-16. [PubMed]
84.
Porzner, M. and Seufferlein, T. Novel approaches to target pancreatic cancer. Current Cancer Drug Targets. 2011. 11, 698-713. [PubMed]
85.
Vincent, A., Herman, J., Schulick, R., Hruban, R. H. and Goggins, M. Pancreatic cancer. Lancet. 2011. 378, 607-620. [PubMed]
86.
Sun, C., Rosendahl, A. H., Andersson, R., Wu, D. and Wang, X. The role of phosphatidylinositol 3-kinase signaling pathways in pancreatic cancer. Pancreatology : Official Journal of the International Association of Pancreatology . 2011. 11, 252-260. [PubMed]
87.
Hong, S. M., Park, J. Y., Hruban, R. H. and Goggins, M. Molecular signatures of pancreatic cancer. Archives of Pathology & Laboratory Medicine. 2011. 135, 716-727. [PubMed]
88.
Stoita, A., Penman, I. D. and Williams, D. B. Review of screening for pancreatic cancer in high risk individuals. World Journal of Gastroenterology : WJG. 2011. 17, 2365-2371. [PubMed]
89.
Ansari, D., Rosendahl, A., Elebro, J. and Andersson, R. Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. The British Journal of Surgery. 2011. 98, 1041-1055. [PubMed]
90.
Singh, P., Srinivasan, R. and Wig, J. D. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment. Pancreas. 2011. 40, 644-652. [PubMed]
91.
Lauth, M. and Toftgard, R. Hedgehog signaling and pancreatic tumor development. Advances in Cancer Research. 2011. 110, 1-17. [PubMed]
92.
Nitsche, C., Simon, P., Weiss, F. U., Fluhr, G., Weber, E., Gartner, S., Behn, C. O., Kraft, M., Ringel, J., Aghdassi, A., Mayerle, J. and Lerch, M. M. Environmental risk factors for chronic pancreatitis and pancreatic cancer. Digestive Diseases. 2011. 29, 235-242. [PubMed]
93.
Zavoral, M., Minarikova, P., Zavada, F., Salek, C. and Minarik, M. Molecular biology of pancreatic cancer. World Journal of Gastroenterology : WJG. 2011. 17, 2897-2908. [PubMed]
94.
Saif M. W. Pancreatic neoplasm in 2011: an update. JOP : Journal of the Pancreas. 2011. 12, 316-321. [PubMed]
95.
Gonda, T. A., Lucas, A. and Saif, M. W. Screening and detection of pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. JOP : Journal of the Pancreas. 2011. 12, 322-324. [PubMed]
96.
Xu, X., Strimpakos, A. S. and Saif, M. W. Biomarkers and pharmacogenetics in pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. JOP : Journal of the Pancreas. 2011. 12, 325-329. [PubMed]
97.
Shi, C. and Hruban, R. H. Intraductal papillary mucinous neoplasm. Human Pathology. 2012. 43, 1-16. [PubMed]
98.
Wang, J. and Sen, S. MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease. Journal of Biosciences. 2011. 36, 481-491. [PubMed]
99.
Brody, J. R., Witkiewicz, A. K. and Yeo, C. J. The past, present, and future of biomarkers: a need for molecular beacons for the clinical management of pancreatic cancer. Advances in Surgery. 2011. 45, 301-321. [PubMed]
100.
Greer, J. B. and Brand, R. E. Screening for pancreatic cancer: current evidence and future directions. Gastroenterology & Hepatology. 2007. 3, 929-938. [PubMed]
101.
Geng, R., Li, Z., Li, S. and Gao, J. Proteomics in pancreatic cancer research. International Journal of Proteomics. 2011. 2011, 365350. [PubMed]
102.
Kwon, R. S. and Simeone, D. M. The use of protein-based biomarkers for the diagnosis of cystic tumors of the pancreas. International Journal of Proteomics. 2011. 2011, 413646. [PubMed]
103.
Pan, S., Chen, R., Stevens, T., Bronner, M. P., May, D., Tamura, Y., McIntosh, M. W. and Brentnall, T. A. Proteomics portrait of archival lesions of chronic pancreatitis. PloS One. 2011. 6, e27574. [PubMed]
